References
- Reid ME, Calhoun L, Petz LD. Erythrocyte antigens and antibodies. In: Lichtman MA, Beutler E, Kipps TJ, et al., Eds. Williams hematology. 7th ed. New York: McGraw-Hill Medical, 2006:2119–36.
- Reid ME, Westhoff CM. Membrane blood group antigens and antibodies. In: Hillyer CD, Silberstein LE, Ness PM, Anderson KC, Roback JD, Eds. Blood banking and transfusion medicine: basic principles and practice. 2nd ed. Philadelphia, PA: Churchhill Livingstone Elsevier, 2007:53–68.
- Contreras M, Daniels G. Red cell immunohaematology: an introduction. In: Hoffbrand AV, Catovsky D, Tuddenham E, Eds. Postgraduate haematology. 6th ed. West Sussex, UK: Wiley-Blackwell, 2011:226–43.
- Modell B, Darlison M. Global epidemiology of haemoglobin disorders and derived service indicators. Bull World Health Organ 2008;86:480–7.
- Serjeant GR. Sickle-cell disease. Lancet 1997;350:725–30.
- Piel FB, Patil AP, Howes RE, et al. Global epidemiology of sickle haemoglobin in neonates: a contemporary geostatistical model-based map and population estimates. Lancet 2013;381: 142–51.
- Fleming AF, Storey J, Molineaux L, et al. Abnormal haemoglobins in the Sudan savanna of Nigeria. I. Prevalence of haemoglobins and relationships between sickle cell trait, malaria and survival. Ann Trop Med Parasitol 1979;73: 161–72.
- Uzoegwu PN, Onwurah AE. Prevalence of haemoglobinopathy and malaria diseases in the population of Old Aguata Division, Anambra State, Nigeria. Biokemstri 2003;15:57–66.
- Nwogoh B, Adewoyin AS, Iheanacho OE, Bazuaye GN. Prevalence of haemoglobin variants in Benin City, Nigeria. Ann Biomed Sci 2012;11:60–4.
- Makani J, Ofori-Acquah SF, Nnodu O, Wonkam A, Ohene-Frempong K. Sickle cell disease: new opportunities and challenges in Africa. Scientific World Journal 2013:2013: 193252. Available from http://dx.doi.org/10.1155/2013/193252. Accessed 26 August 2021
- Lesi FE. Problems related to the management of sickle cell disease in Nigeria. Am J Pediatr Hematol Oncol 1982;4:55–9.
- Lal A, Vinchinsky EP. Sickle cell disease. In: Hoffbrand AV, Catovsky D, Tuddenham EGD, Green AR, Eds. Postgraduate haematology. 6th ed. London: Blackwell Publishing, 2011: 109–25.
- Genetic disorders of haemoglobin. In: Hoffbrand AV, Moss PAH, Pettit JE, Eds. Essential haematology. 5th ed. London: Blackwell Publishing, 2006:72–93.
- Hsieh MM, Tisdale JF, Rodgers GP. Haemolytic anaemia: thalassemias and sickle cell disorders. In: Rodgers GP, Young NS, Eds. The Bethesda handbook of clinical haematology. 3rd ed. Philadelphia, PA: Lippincott Williams and Wilkins, 2013:37–56.
- Galacteros F, de Montalembert M. Sickle cell disease: a short guide to management. In: Beaumont C, Beris P, Beuzard Y, Brugnara C, Eds. ESH handbook on disorders of erythropoiesis, erythrocytes and iron metabolism. Available from https://www.esh.org/files/doc/IRON2009_CAP.13.1%28310-327%29.pdf. Accessed 26 August 2021.
- Wayne AS, Kevy SV, Nathan DG. Transfusion management of sickle cell disease. Blood 1993;81:1109–23.
- Rogers ZR. Review: clinical transfusion management in sickle cell disease. Immunohematology 2006;22:126–31.
- Lagunju AI, Brown BJ, Sodeinde OO. Chronic blood transfusion for primary and secondary stroke prevention in Nigerian children with sickle cell disease: a five-year appraisal. Pediatr Blood Cancer 2013;60:1940–5.
- Diaku-Akinwumi IN, Abubakar SB, Adegoke SA, et al. Blood transfusion services for patients with sickle cell disease in Nigeria. Int Health 2016;pii:ihw014.
- Otaigbe B. Prevalence of blood transfusion in sickle cell anaemia patients in South-South Nigeria: a two-year experience. Int J Med Med Sci Res 2013;1:13–8.
- Animasahun BA, Bode-Thomas F, Temiye EO, Njokanma OF. Clinical profile of Nigerian children with sickle cell anaemia. Curr Pediatr Res 2013;17:95–9.
- Hauck-Dlimi B, Achenbach S, Strobel J, Eckstein R, Zimmermann R. Prevention and management of transfusion-induced alloimmunization: current perspectives. Int J Clin Transfus Med 2014;2:59–63.
- Contreras M, Taylor Clare PF, Barbara JA. Clinical blood transfusion. In: Hoffbrand AV, Catovsky D, Tuddenham EGD, Green AR, Eds. Postgraduate haematology. 6th ed. West Sussex: Wiley-Blackwell, 2011:268–99.
- Cox JV, Steane E, Cunningham G, Frenkel E. Risk of alloimmunization and delayed haemolytic transfusion reactions in patients with sickle cell disease. Arch Intern Med 1988;148:2485–9.
- Kuliya-Gwarzo A, Akanmu AS, Dutse AI. Prevalence of red cell alloantibodies in multitransfused patients with sickle cell anaemia in Northern Nigeria. Africa Sang 2005;8:1–4.
- Ugwu NI, Awodu OA, Bazuaye GN, Okoye AE. Red cell alloimmunisation in multi-transfused patients with sickle cell anaemia in Benin City, Nigeria. Niger J Clin Pract 2015;18:522–6.
- Kangiwa U, Ibegbulam O, Ocheni S, Madu A, Mohammed N. Pattern and prevalence of alloimmunisation in multiply transfused patients with sickle cell disease in Nigeria. Biomarker Res 2015;3:26.
- Natukunda B, Schonewille H, Ndugwa C, Brand A. Red blood cell alloimmunization in sickle cell disease patients in Uganda. Transfusion 2010;50:20–5.
- Zanetter AMD, Goncalves MS, Schettini LV, et al. Alloimmunisation and clinical profile of sickle cell disease patients from Salvador-Brazil. Ethn Dis 2010;20:136–41.
- Olujohungbe A, Hambleton I, Stephens L, Serjeant B, Sergeant G. Red cell antibodies in patients with homozygous sickle cell disease: a comparison of patients in Jamaica and the United Kingdom. Br J Haematol 2001;113:661–5.
- Bashawri LAM. Red cell alloimmunisation in sickle cell anaemia patients. East Mediterr Health J 2007;13:1181–9.
- Sins JMR, Biermond BJ, van den Bersselaar SM, et al. Early occurrence of red blood cell alloimmunization in patients with sickle cell disease. Am J Hematol 2016;91:763–9.
- Verduin EP, Brand A, Middleburg RA, Schonewille H. Female sex of older patients is an independent risk factor for red blood cell alloimmunisation after transfusion. Transfusion 2015;55:1478–85.
- Allali S, Peyrard T, Amiranoff D, et al. Prevalence and risk factors for red blood cell alloimmunisation in 175 children with sickle cell disease in a French University Hospital Reference Centre. Br J Haematol 2017;177:641–7.
- Desai PC, Deal AM, Pfaff ER, et al. Alloimmunisation is associated with older age of transfused red blood cells in sickle cell disease. Am J Hematol 2015;90:691–5.
- Garg N, Sharma T, Singh B. Prevalence of irregular red blood cell antibodies among healthy blood donors in Delhi population. Transfus Apher Sci 2014;50:415–7.
- Roback JD, Combs MR, Grossman BJ, et al., Eds. Technical manual. 16th ed. Bethesda, MD: American Association of Blood Banks, 2008.
- Regan F. Blood cell antigens and antibodies: erythrocytes, platelets and granulocytes. In: Bain BJ, Bates I, Laffan MA, Lewis SM, Eds. Dacie and Lewis practical haematology. 11th ed. London: Elsevier Churchill Livingstone Publishers, 2012:483–517.
- Schonewille H, Haak HL, van Zijl AM. RBC antibody persistence. Transfusion 2000;40:1127–31.
- Josephson CD, Su LL, Hillyer KL, Hillyer CD. Transfusion in the patient with sickle cell disease: a critical review of literature and transfusion guidelines. Trans Med Rev 2007;21:118–33.
- Natukunda B, Schonewille H, Ndugwa C, Brand A. Red blood cell alloimmunisation in sickle cell disease patients in Uganda. Transfusion 2010;50:20–5.